The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their ...

Diabetic macular edema can result in low vision or ... When fluid gets into the retina’s center part, called the macula, it causes swelling. This can affect vision and, in some cases, lead ...

6, 2025 — The FDA has approved a new implantable treatment for adults with diabetic macular edema (DME ... causing fluid leakage and swelling in the macula — the part of the eye responsible ...

The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema. Susvimo is the first and only FDA-approved treatment shown to ...

The global diabetic macular edema market is on a steady growth trajectory, with an expected valuation of approximately USD 4,120.9 million in 2024. The market is poised to surpass USD 4,642.9 million ...

US-based biotechnology company Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic macular oedema (DMO) treatment. The open-label, dose-escalation trial will ...

The patients were diagnosed with type 1 or type 2 diabetes mellitus ... A Cirrus HD-OCT 4000 (software Version 6.0) was used to obtain the macular images. The patients placed their chins in ...

EyePoint Pharmaceuticals Inc. (EYPT), which reported positive interim 16-week data from its phase II VERONA clinical trial last ...

There are around 537 million suffering with diabetes globally. Out of this, around 227 million people live in the Asia Pacific region. What is concerning is the fact that more than half of these ...

Over 537 million people globally suffer from diabetes, with 227 million in Asia Pacific. More than half may develop diabetic retinopathy (DR) within 10 years, potentially leading to blindness.